PEDIA-LAX ENEMA OTC
Generic Name and Formulations:
Monobasic sodium phosphate 9.5g, dibasic sodium phosphate 3.5g; per 59mL; latex-free; contains 2.2g sodium per enema.
Fleet, C.B., Company
Indications for PEDIA-LAX ENEMA:
Occasional constipation or bowel cleansing before rectal exam.
<2yrs: do not use. 2–4yrs: ½ enema rectally. 5–11yrs: 1 enema rectally. Results usually in 1–5 min; reevaluate if ineffective.
CHF. Ascites. Severe renal impairment. GI or GU obstruction. Megacolon. Imperforate anus.
Sodium-restricted diet. Impaired renal or cardiac function. Electrolyte disturbances. Colostomy. Discontinue if rectal bleeding or if no bowel movement occurs. Frequent use leads to dependence.
Electrolyte imbalances possible with calcium channel blockers, diuretics; use cautiously.
Endocrinology Advisor Articles
- Soluble Klotho Levels Predictive of Kidney Failure in Type 2 Diabetes
- Clinicians May Be Overtreating Older Patients With Diabetes
- Comorbid and Pharmacologic Factors Increase Risk for Gastrointestinal Disorders in Diabetes
- Obesity Risk in Infants Born to Women With Diabetes
- Increased Risk for Mortality in People With Diabetes, CHD Taking Beta-Blockers
- Diabetes May Decrease Ability to Feel Acid Regurgitation
- Autism Does Not Affect Metabolic Control in Type 1 Diabetes
- Hormonal Contraceptives May Adversely Affect Psychological Health in Adolescent Girls
- Obesity Can Negatively Effect Liver in Children as Young as 8
- Recommendations Developed on Gender Equity in Medicine